Carcinogenesis and hallmarks of cancer Flashcards
electrophiles
many carcinogens are strong electrophiles that accept electrons
3 steps
initiation
promotion (reversible)
progression (irreversible)
smoking
causes chronic inflammation, and repair, which will eventually lead to cancer
radiation
ionising - very high energy. inc cosmic rays & X-rays
non-ionising - less energy. inc UV rays
ionising radiation
damages cellular structures and DNA
displaces electrons from atoms resulting in an ion pair
bone marrow, thyroid and breast tissue are particularly susceptible
radiation therapy
splitting the dose will diminish the acute toxicity of the dose
only 3x the radiation received from therapy is fatal
non-ionisning
UV A/B/C
C is the most potent but most is absorbed in the air
nucleotide excision repair pathway
repairs distortions caused by UV radiation
errors in this pathway increase the risk of UV radiation
highest risk factors for cancer
- diet
- smoking
- infections
oncogenic mutation
single mutation
dominant gene
gain of function triggering the development of cancer
tumour suppressor genes
recessive
therefore requires 2 mutations
involve loss of function to develop cancer
multistep carcinogenesis
90% of all human cancers are not familial
not the consequence of known familial factors`
cancer and tissue oxygenation
cancers are hypoxic, and grow in a low oxygen environment
O2 can only diffuse 150microns
therefore only a very small portion of the tumour will be oxygenated due to distance between cancer cells and blood vessels (also makes it difficult to deliver anti-cancer medications into tumour)
blood vessels supplying blood to tumours are also hypoxic
tyrosine kinase
HER1/2/3/4 requires dimerisation HER1+1 normal, less proliferation HER1=2 heterodimer is more proliferative if a mutation triggers more HER2, then more heterodimers form, and more proliferation
combretastatin A4
cuts of blood supply to endothelium surrounding tumor, depriving the tumour of blood
does cause ischaemic tumour pain, but effective at reducing tumour cells, particularly when given after chemo, whereby it can ‘trap’ the chemo agents within the tumour